Palliative Care and Location of Death in Decedents With Idiopathic Pulmonary Fibrosis

被引:124
作者
Lindell, Kathleen O. [1 ,2 ]
Liang, Zhan [3 ]
Hoffman, Leslie A. [3 ]
Rosenzweig, Margaret Q. [3 ]
Saul, Melissa I. [4 ]
Pilewski, Joseph M. [2 ]
Gibson, Kevin F. [1 ,2 ]
Kaminski, Naftali [5 ]
机构
[1] Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lu, UPMC, Pittsburgh, PA USA
[2] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Dept Biomed Informat, Sch Med, Pittsburgh, PA 15261 USA
[5] Yale Univ, Sch Med, New Haven, CT USA
基金
美国国家卫生研究院;
关键词
INTERSTITIAL LUNG-DISEASE; QUALITY-OF-LIFE; SURVIVAL; MANAGEMENT; PATIENT; SYSTEM;
D O I
10.1378/chest.14-1127
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Palliative care, integrated early, may reduce symptom burden in patients with idiopathic pulmonary fibrosis (IPF). However, limited information exists on timing and clinical practice. The purpose of this study was to describe the time course of events prior to death in patients with IPF managed at a specialty center with a focus on location of death and timing of referral for palliative care. METHODS: Data were retrospectively extracted from the health system's data repository and obituary listings. The sample included all decedents, excluding lung transplant recipients, who had their first visit to the center between 2000 and 2012. RESULTS: Median survival for 404 decedents was 3 years from diagnosis and 1 year from first center visit. Of 277 decedents whose location of death could be determined, > 50% died in the hospital (57%). Only 38 (13.7%) had a formal palliative care referral and the majority (71%) was referred within 1 month of their death. Decedents who died in the academic medical center ICU were significantly younger than those who died in a community hospital ward (P = .04) or hospice (P = .001). CONCLUSIONS: The majority of patients with IPF died in a hospital setting and only a minority received a formal palliative care referral. Referral to palliative care occurred late in the disease. These findings indicate the need to study adequacy of end-of-life management in IPF and promote earlier discussion and referral to palliative care.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 50 条
  • [41] Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis
    Hook, J. L.
    Arcasoy, S. M.
    Zemmel, D.
    Bartels, M. N.
    Kawut, S. M.
    Lederer, D. J.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (02) : 359 - 365
  • [42] Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
    Maher, Toby M.
    Strek, Mary E.
    RESPIRATORY RESEARCH, 2019, 20 (01)
  • [43] Development and applicability of a dignity-centred palliative care programme for people with idiopathic pulmonary fibrosis: A qualitative-driven mixed methods study
    Igai, Yasuko
    Porter, Sarah E.
    NURSING OPEN, 2023, 10 (01): : 8 - 23
  • [44] Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
    Strykowski, Rachel
    Adegunsoye, Ayodeji
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) : 209 - 228
  • [45] Palliative care for patients with pulmonary fibrosis: symptom relief is essential
    Lindell, Kathleen
    Raghu, Ganesh
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (06)
  • [46] Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions
    Ferrara, Giovanni
    Luppi, Fabrizio
    Birring, Surinder S.
    Cerri, Stefania
    Caminati, Antonella
    Skold, Magnus
    Kreuter, Michael
    EUROPEAN RESPIRATORY REVIEW, 2018, 27 (147)
  • [47] Advances in understanding of idiopathic pulmonary fibrosis
    Wang Zeng-li
    CHINESE MEDICAL JOURNAL, 2009, 122 (07) : 844 - 857
  • [48] Idiopathic pulmonary fibrosis: pathogenesis and management
    Giacomo Sgalla
    Bruno Iovene
    Mariarosaria Calvello
    Margherita Ori
    Francesco Varone
    Luca Richeldi
    Respiratory Research, 19
  • [49] Nintedanib for the treatment of idiopathic pulmonary fibrosis
    Varone, Francesco
    Sgalla, Giacomo
    Iovene, Bruno
    Bruni, Teresa
    Richeldi, Luca
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (02) : 167 - 175
  • [50] Managing comorbidities in idiopathic pulmonary fibrosis
    Fulton, Blair G.
    Ryerson, Christopher J.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2015, 8 : 309 - 318